Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry.
Vincenzo L MalavasiMarco VitoloMarco ProiettiIgor DiembergerLaurent FauchierFrancisco MarinMichael NabauerTatjana S PotparaGheorghe-Andrei DanZbigniew KalarusLuigi TavazziAldo Pietro MaggioniDeirdre A LaneGregory Y H LipGiuseppe Borianinull nullPublished in: European journal of clinical investigation (2022)
In a large contemporary cohort of AF patients, active malignancy was independently associated with all-cause death, MACE and haemorrhagic events. Use of anticoagulants was not associated with a higher risk of all-cause death in patients with active malignancies.
Keyphrases
- atrial fibrillation
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- heart failure
- randomized controlled trial
- left atrial
- percutaneous coronary intervention
- type diabetes
- clinical trial
- catheter ablation
- venous thromboembolism
- skeletal muscle
- coronary artery disease
- glycemic control